[Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report

Key facts

  • [Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report
  • Source: PR Times
  • Date: May 13, 2026

Direct answer

Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For the period from January 1 to March 31, 2026, the company reported cumulative operating revenue of TWD 4,001,231 thousand, gross profit of TWD 1,441,258 thousand, and operating income of TWD 407,236 thousand. Net income attributable to owners of the parent was TWD 25,838 thousand, with basic earnings per share (EPS) at TWD 0.21. Total assets stood at TWD 45,331,756 thousand. The net income include

Citation
[Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report (May 13, 2026), PR Times
Source
PR Times
Date
May 13, 2026
出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 13, 2026 at 09:00
  • 🔍 Collected: May 14, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 15, 2026 at 08:23 (24h 23m after Collected)
Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For the period from January 1 to March 31, 2026, the company reported cumulative operating revenue of TWD 4,001,231 thousand, gross profit of TWD 1,441,258 thousand, and operating income of TWD 407,236 thousand. Net income attributable to owners of the parent was TWD 25,838 thousand, with basic earnings per share (EPS) at TWD 0.21. Total assets stood at TWD 45,331,756 thousand. The net income includes a discontinued operations loss of TWD 14,449 thousand.

FAQ

What are the key facts in this article?

Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For the period from January 1 to March 31, 2026, the company reported cumulative operating revenue of TWD 4,001,231 thousand, gross profit of TWD 1,441,258 thousand, and operating income of TWD 407,236 thousand. Net income attributable to owners of the parent was TWD 25,838 thousand, with basic earnings per share (EPS) at TWD 0.21. Total assets stood at TWD 45,331,756 thousand. The net income include

What is the direct answer?

Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For the period from January 1 to March 31, 2026, the company reported cumulative operating revenue of TWD 4,001,231 thousand, gross profit of TWD 1,441,258 thousand, and operating income of TWD 407,236 thousand. Net income attributable to owners of the parent was TWD 25,838 thousand, with basic earnings per share (EPS) at TWD 0.21. Total assets stood at TWD 45,331,756 thousand. The net income include

What is the source and date?

PR Times: https://mops.twse.com.tw/material/twse-6472-2026-05-13-2b9c8d7f | May 13, 2026

Back to Newsroom (168)